| CAS: | 79794-75-5 | |||
| 分子式: | C22H23ClN2O2 | |||
| 分子量: | 382.88 | |||
| 中文名称: |
| |||
| 英文名称: |
| |||
| 用途: | 国家二类抗过敏新药。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||
| 767188 | MACKLIN | 氯雷他定标准溶液 | 100μg/mL in Methanol | 510元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
储存:2-8°C, 避光 | |||||||||||||||||||||||||||||||||||||||||||||||||
| L838244 | MACKLIN | 氯雷他定 | > 98 % HPLC, powder | 29元/100mg; 36元/500mg; 45元/1g; 62元/5g; 205元/25g; 801元/100g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
储存:4°C 状态:白色到灰白色固体 | |||||||||||||||||||||||||||||||||||||||||||||||||
| L793860 | MACKLIN | 氯雷他定 | 10mM in DMSO | 362元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||
| L0223 | TCI | Loratadine | >98.0%(T)(HPLC) | 475元/100MG; 1265元/1G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 338442 | J&K | Loratadine | 98%, 一种高效选择性的H1受体拮抗剂 | 60元/100mg; 131元/1g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Loratadine是一种选择性的histamine H1 receptor拮抗剂,用于治疗过敏。同时还是一种选择性的B(0)AT2抑制剂,其IC50为 4 μM。 靶点(IC50 & Targe) B(0)AT2,4μM 体外研究 Loratadine被确定为B(0)AT 2的选择性抑制剂,IC 50为4 μM,对SLC6家族的几个其它成员低活性或无活性。[1] 在Der p 1和或抗Fc小量RI预培养的人Fc小量的RI+细胞,Loratadine浓度依赖性抑制组胺和白三烯C4的释放。在抗Fc小量RI激活的纯化HLMC中,Loratadine(0.1 mM)也抑制组胺,白三烯C4和PGD2的释放。在抗Fc小量RI刺激的纯化HSMC中,Loratadine浓度依赖性抑制组胺,类胰蛋白酶,LTC4和PGD 2的释放。[1] 在人脐静脉内皮细胞,Loratadine显著抑制组胺诱导的IL-6和IL-8的分泌。[3] 在转染了hKv1.5通道基因的人Ltk-细胞中,Loratadineh在浓度高于治疗性血浆水平时以浓度,电压,时间和使用依赖性的方式阻断Kv1.5通道。[4]在主支气管或转化(A549)呼吸道上皮细胞中,Loratadineh抑制rhinovirus诱导的ICAM-1的上调。Loratadineh也以剂量依赖的方式抑制鼻病毒感染诱导的ICAM-1的mRNA,并且它们完全抑制鼻病毒诱导的ICAM-1启动子的活化。[5] 参考文献 [1] Cuboni S, et al. J Med Chem, 2014, 57(22), 9473-9479. [2] Genovese A, et al. Clin Exp Allergy, 1997, 27(5), 559-567. [3] Molet S, et al. Clin Exp Allergy, 1997, 27(10), 1167-1174. [4] Delp髇 E, et al. Cardiovasc Res, 1997, 35(2), 341-350. [5] Papi A, et al. J Allergy Clin Immunol, 2001, 108(2), 221-228. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1376 | Supelco | Loratadine | Pharmaceutical Secondary Standard; Certified Reference Material | 1669.88元/1 G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Loratadine belongs to the class of H1-antihistamine drugs, with non-sedating properties, and is widely used in the treatment of allergies. 应用 Loratadine may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using spectrophotometric technique. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC3785 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000688 | Loratadine | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 包装 Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000603 | Loratadine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| L9664 | Sigma-Aldrich | Loratadine | ≥98% (HPLC), powder | 2297.06元/10 MG; 6337.89元/50 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 氯雷他定是一种非镇静性组胺H1受体拮抗剂。其可抑制双孔结构域钾通道K2P18.1(也称为TRESK或KCNK18)。 特点和优势 该化合物由Schering Plough开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。 其他说明 斯克里普斯代谢组学和质谱技术中心独立生成的串联质谱数据可在PDF L9664.pdf 中查看或下载。斯克里普斯代谢物组学和质谱技术中心的METLIN代谢物数据库中有测试代谢物。要了解更多信息,请访问sigma.com/metlin。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 1370270 | USP | Loratadine | United States Pharmacopeia (USP) Reference Standard | 5402.06元/200 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| BP874 | Loratadine | British Pharmacopoeia (BP) Reference Standard | 2189.77元/100 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||
| BP875 | Loratadine impurity standard | British Pharmacopoeia (BP) Reference Standard | 1916.08元/25 MG; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非镇静组胺H1-受体拮抗剂。 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||